TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IMUX

Immunic Inc

Healthcare · Biotechnology

10.60$ +2.6% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Immunic Inc (IMUX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 08/11/2026
Earnings surprise by quarter (%)
Q3 23 · -0.6 % 23 Q4 23 · 5.9 % 23 Q1 24 · -13.2 % 24 Q2 24 · 9.9 % 24 Q3 24 · -10.1 % 24 Q4 24 · -5.0 % 24 Q1 25 · 0.0 % 25 Q2 25 · -11.1 % 25 Q3 25 · 26.6 % 25 Q4 25 · -20.0 % 25 Q1 26 · -12.5 % 26 Q2 26 · 35.5 % 26

EPS estimate beaten

Full history 20 of 50 quarters (40%)
Last 16 quarters 6 of 16 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/11/2026 IMMUNIC, INC. (IMUX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/09/2026 IMMUNIC, INC. (IMUX): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/11/2026 IMMUNIC, INC. (IMUX): Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/14/2026 IMMUNIC, INC. (IMUX): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/06/2026 IMMUNIC, INC. (IMUX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?